Brammer Bio Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Brammer Bio Inc.
The number of gene therapies in development continues to rise, as trial sponsors widen the scope of addressable conditions, beyond ultra-rare diseases. Will manufacturing capacity – and payer budgets – be able to keep up?
- Contract Research, Toxicology Testing-CRO
- Gene Therapy, Cell Therapy
- Large Molecule